Akero Therapeutics Inc (NQ: AKRO )
26.87
+0.11
(+0.41%)
Streaming Delayed Price
Updated: 12:39 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Akero Therapeutics Inc
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_2538.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/aapharma_8.png?width=1200&height=800&fit=crop)
Thanks To Encouraging Data, These Mid-Cap Stocks Layout $300M Equity Raise
September 14, 2022
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://www.investors.com/wp-content/uploads/2019/10/stock-drugs-needle-01-adobe.jpg)
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
January 27, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/22/akro_logo_light__e458157c4220ab115cc99a5efdd1c25b.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/19/image_2.jpg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 19, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH
December 08, 2022
From Akero Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
From Akero Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22263.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
November 25, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://prudentbiotech.com/wp-content/uploads/2022/10/Yield-and-XBI.jpg)
![](https://ml.globenewswire.com/media/cb85fa28-c91f-4e69-9ab0-37bd11d39425/small/akero-logo-with-white-space-1-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/30/image-carnival_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/03/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/30/image-micron-technology_0.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.